Union Savings Bank trimmed its position in Danaher Co. (NYSE:DHR – Free Report) by 4.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,557 shares of the conglomerate’s stock after selling 207 shares during the period. Union Savings Bank’s holdings in Danaher were worth $1,046,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently made changes to their positions in DHR. Coronation Fund Managers Ltd. raised its holdings in shares of Danaher by 29.9% in the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after acquiring an additional 1,470 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its position in shares of Danaher by 14.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 10,260 shares of the conglomerate’s stock worth $2,563,000 after purchasing an additional 1,321 shares during the last quarter. Bridges Investment Management Inc. purchased a new stake in Danaher in the second quarter valued at approximately $240,000. AE Wealth Management LLC lifted its position in Danaher by 10.8% during the second quarter. AE Wealth Management LLC now owns 15,619 shares of the conglomerate’s stock valued at $3,903,000 after purchasing an additional 1,518 shares during the last quarter. Finally, Legacy Financial Advisors Inc. grew its stake in Danaher by 5.2% in the 2nd quarter. Legacy Financial Advisors Inc. now owns 2,585 shares of the conglomerate’s stock worth $646,000 after buying an additional 127 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research firms have recently weighed in on DHR. UBS Group lowered their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and set a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Citigroup reduced their price objective on Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. KeyCorp raised their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, Raymond James cut their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $286.80.
Danaher Stock Performance
Danaher stock opened at $238.41 on Monday. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70. The firm has a market cap of $172.20 billion, a P/E ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a 50-day moving average of $234.85 and a 200-day moving average of $253.42.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company earned $2.02 EPS. Sell-side analysts expect that Danaher Co. will post 7.49 EPS for the current year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is currently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Most Volatile Stocks, What Investors Need to Know
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Investing In Preferred Stock vs. Common Stock
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
- Using the MarketBeat Stock Split Calculator
- There May Still Be Time to Get in on These 3 Trending Biotechs
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.